{
    "nctId": "NCT05594498",
    "briefTitle": "A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients",
    "officialTitle": "A Pilot Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients Undergoing Adjuvant Radiotherapy",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Radiation Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Clinician grading of acute skin toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Informed consent\n* Histological confirmation of breast malignancy (invasive or in situ carcinoma) or phyllodes\n* Patient are scheduled to receive conventionally - (50 Gy/25) or hypofractionated (40 Gy/15 or 42.6 Gy/16)\n* Can communicate in English or be aided by a translator\n\nExclusion Criteria:\n\n* Patient had previous radiation therapy to the treatment area\n* Patient will receive partial breast external beam radiation or brachytherapy\n* Patients scheduled to receive extreme hypofractionation (26 Gy/ 5)\n* Patients with active rash, pre-existing dermatitis, or other conditions within the treatment area that may make skin assessment for the study difficult per treating physician discretion.\n* Patients with known allergy or sensitivity to silicone\n* Concomitant cytotoxic chemotherapy\n* Bilateral breast pathology requiring concurrent bilateral breast radiation",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}